Posts Tagged ‘ Reuters ’

Consumer Reports Campaign email Alerts Million About Defective Medical Devices

Mar 13th, 2012 | By
Consumer Reports Campaign email Alerts Million About Defective Medical Devices

MARCH 12, 2012 ~ How bad are medical devices approved by the U.S. Food and Drug Administration? Reuters reports (here) that Consumer Reports believes they are very bad. The president of the 76-year-old publication wrote in an email to 1 million subscribers this year that, “The implant that fixed your knee or your heart may
[continue reading...]



Bad Apples and the Defective Silicone Breast Implants Distributed Worldwide

Jan 10th, 2012 | By
Bad Apples and the Defective Silicone Breast Implants Distributed Worldwide

JANUARY 10, 2012 ~ The front-page headlines in Europe concern substandard and defective breast implants made by the French company Poly Implants Protheses (PIP) that ruptured and deflated leaking machine-grade silicone in the women who had the implants to enhance their appearance or to mask the effects of disfiguring breast surgery. Share this:



Medtronic Pays $23 Million to Settle Doctor Kickback Charges

Dec 18th, 2011 | By
Medtronic Pays $23 Million to Settle Doctor Kickback Charges

Medtronic is the world’s top maker of medical devices and it didn’t get that way without help. The U.S. Department of Justice accused the Minnesota-based company of having friends in high places – Share this:



U.S. Advisers Call for New Medical Device Regime, Reuters July 29, 2011

Aug 14th, 2011 | By
U.S. Advisers Call for New Medical Device Regime, Reuters July 29, 2011

The FDA is pushing back on an Institute of Medicine recommendation that the fast-track approval process for medical devices is fatally flawed and should be replaced, reports Reuters. FDA’s Jeffrey Shuren, director of the Center for Devices and Radiological Health, which oversees devices, said the 510(k) process should not be eliminated, but “we are open
[continue reading...]



We hope you find this a helpful resource. National News Editor, Jane Akre, began MDND with the hope of providing the latest news, information and perspective from the regulatory, industry and patient point of view, something that goes under-reported in much of the coverage of medical devices. The public is just now becoming aware that many devices do not undergo the same scrutiny as prescription drugs and are instead grandfathered in under an FDA loophole that has gone largely unchanged since the 1970s. As a result, patients become the post-market clinical trial subjects, and many suffer devastating and permanent injuries.